Cargando…
Evaluation of the safety profile of COVID-19 vaccines in patients with MS, NMOSD, and MOGAD
INTRODUCTION: Vaccination against the coronavirus disease 2019 (COVID-19) is recommended for patients with multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). However, vaccine safety in these patients t...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924883/ https://www.ncbi.nlm.nih.gov/pubmed/36781562 http://dx.doi.org/10.1007/s10072-023-06676-1 |